Impact of UK Medical Eligibility Criteria implementation on prescribing of combined hormonal contraceptives

Journal of Family Planning and Reproductive Health Care

Volumn 39, Issue 3, 2013, Pages 190-196

  Briggs, Paula Elizabeth ^a   Praet, Cecile Aude ^b   Humphreys, Samantha Charlotte ^b   Zhao, Changgeng ^c  

^a SOUTHPORT AND ORMSKIRK HOSPITAL NHS TRUST   (United Kingdom)

^b MSD Development Laboratories   (United Kingdom)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMBINED HORMONAL CONTRACEPTIVE; CONTRACEPTIVE AGENT; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTRACEPTIVE BEHAVIOR; CROSS-SECTIONAL STUDY; DRUG USE; FEMALE; GENERAL PRACTICE; HEALTH CARE PLANNING; HIGH RISK POPULATION; HORMONAL CONTRACEPTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PRESCRIPTION; PUBLICATION; SMOKING; UNITED KINGDOM;

CARDIOVASCULAR DISEASES; FAMILY PLANNING SERVICE PROVISION; HORMONAL CONTRACEPTION; OBESITY; ORAL CONTRACEPTIVES; SMOKING;

ADOLESCENT; ADULT; CARDIOVASCULAR DISEASES; CONTRACEPTIVES, ORAL, COMBINED; CROSS-SECTIONAL STUDIES; ELIGIBILITY DETERMINATION; FEMALE; GREAT BRITAIN; HUMANS; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; RISK ASSESSMENT; RISK FACTORS; YOUNG ADULT;

EID: 84879390216     PISSN: 14711893     EISSN: None     Source Type: Journal    
DOI: 10.1136/jfprhc-2012-100376     Document Type: Article

References (27)

1. IMS Disease Analyzer. September 2011. As interpreted by MSD Ltd.
2. Lidegaard O, Lokkegaard E, Svendsen AL, et al. Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ 2009;339:b2890.
3. van Hylckama Vlieg A, Helmerhorst FM, Vandenbroucke JP, et al. The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ 2009;339:b2921.
4. Dinger JC, Heinemann LA, Kuehl-Habich D. The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance study on oral contraceptives based on 142,475 women-years of observation. Contraception 2007;75:344-354. (Pubitemid 46551071)
5. Gillum LA, Mamidipudi SK, Johnston SC. Ischemic stroke risk with oral contraceptives. JAMA 2000;284:72-78. (Pubitemid 30445664)
6. World Health Organization. Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet 1996;348:498-505.
7. Khader YS, Rice J, John L, et al. Oral contraceptives use and the risk of myocardial infarction: a meta-analysis. Contraception 2003;68:11-17. (Pubitemid 37271985)
8. Vandenbroucke JP, Koster T, Rosendaal FR, et al. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994;344:1453-1457. (Pubitemid 24351698)
9. Thorogood M, Mann J, Murphy M, et al. Risk factors for fatal venous thromboembolism in young women - a case-control study. Int J Epidemiol 1992;21:48-52.
10. Poulter NR, Chang CL, Farley TMM, et al. Venous thromboembolic disease and combined oral contraceptives - results of International Multicenter Case-Control Study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet 1995;346: 1575-1582. (Pubitemid 26001838)
11. Sidney S, Petitti DB, Soff GA, et al. Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives. Contraception 2004;70:3-10. (Pubitemid 38781972)
12. Faculty of Sexual and Reproductive Healthcare Clinical Effectiveness Unit. Combined Hormonal Contraception. 2011. http://www.fsrh.org/pdfs/ CEUGuidanceCombinedHormonal Contraception.pdf [accessed 26 February 2012].
13. Nightingale AL, Lawrenson RA, Simpson EL, et al. The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptives. Eur J Contracept Reprod Health Care 2000;5:265-274. (Pubitemid 32165465)
14. Pomp ER, le Cessie S, Rosendaal FR, et al. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. Br J Haematol 2007;139:289-296. (Pubitemid 47493087)
15. Chang CL, Michael D, Neil P. Migraine and stroke in young women: case-control study. BMJ 1999;318:13-18. (Pubitemid 29188891)
16. MacGregor EA. Migraine and use of combined hormonal contraceptives: a clinical review. J Fam Plann Reprod Health Care 2007;33:159-169. (Pubitemid 47057431)
17. Faculty of Family Planning and Reproductive Health Care. UK Medical Eligibility Criteria for Contraceptive Use (UKMEC 2005/2006). 2006. http://www.fsrh.org/pdfs/archive/UKMEC2005-06.pdf [accessed 26 February 2012].
18. World Health Organization. Medical Eligibility Criteria for Contraceptive Use (3rd edn). 2004. http://www.who.int/reproductive-health/publications/mec/ index.htm [accessed 26 February 2012].
19. Faculty of Sexual and Reproductive Healthcare. UK Medical Eligibility Criteria for Contraceptive Use (UKMEC 2009). 2009. http://www.fsrh.org/pdfs/ UKMEC2009.pdf [accessed 26 February 2012].
20. The General Practice Research Database. http://www.gprd.com [accessed 26 February 2012].
21. The Clinical Research Practice Datalink http://www.cprd.com/intro.asp [accessed 20 July 2012].
22. Williams T, Puri S. The General Practice Research Database. 2010. http://ecomms.eu.watsonwyatt.com/towers-watson/IFS-events/15040-Mortality- Seminar/pdf/Session1- WilliamsPuri.pdf [accessed 16 April 2012].
23. Office for National Statistics. Population Estimates for UK, England and Wales, Scotland and Northern Ireland - Mid-2010. http://www.ons.gov.uk/ons/rel/ pop-estimate/population-estimates-for-uk-england-and-wales-scotland-andnorthern- ireland/index.html [accessed 26 February 2012].
24. World Health Organization. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Contraception 1998; 57:315-324.
25. The NHS Information Centre for Health and Social Care. Health and Lifestyles. http://www.ic.nhs.uk/statistics-and-datacollections/health-and- lifestyles [accessed 26 February 2012].
26. National Institute for Health and Clinical Excellence. Long-acting Reversible Contraception (Clinical Guideline 30). 2005. http://publications. nice.org.uk/long-acting-reversiblecontraception- cg30 [accessed 26 February 2012].
27. Grove D, Hooper DJ. Doctor contraceptive-prescribing behaviour and women's attitudes towards contraception: two European surveys. J Eval Clin Pract 2011;17:493-502.